Clinical Trial Update: A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial at the University of Chicago evaluating LP-118 with ponatinib, vincristine, and dexamethasone for relapsed/refractory acute lymphobla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Lymphoblastic Lymphoma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• LP-118
• Ponatinib (ponatinib)
• Vincristine (vincristine)

Snippet

Sponsor: University of Chicago | Conditions: Acute Leukemia, Lymphoblastic Leukemia | Phase 1, Phase 2 | Status: RECRUITING